GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (LSE:OPTI) » Definitions » Current Ratio

OptiBiotix Health (LSE:OPTI) Current Ratio

: 3.59 (As of Jun. 2023)
View and export this data going back to 2011. Start your Free Trial

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. OptiBiotix Health's current ratio for the quarter that ended in Jun. 2023 was 3.59.

OptiBiotix Health has a current ratio of 3.59. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for OptiBiotix Health's Current Ratio or its related term are showing as below:

LSE:OPTI' s Current Ratio Range Over the Past 10 Years
Min: 3.59   Med: 8   Max: 48.92
Current: 3.59

During the past 12 years, OptiBiotix Health's highest Current Ratio was 48.92. The lowest was 3.59. And the median was 8.00.

LSE:OPTI's Current Ratio is ranked worse than
51.8% of 1556 companies
in the Biotechnology industry
Industry Median: 3.795 vs LSE:OPTI: 3.59

OptiBiotix Health Current Ratio Historical Data

The historical data trend for OptiBiotix Health's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Annual Data
Trend Jul10 Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22
Current Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.47 3.90 3.86 6.40 6.68

OptiBiotix Health Semi-Annual Data
Jul12 Jan13 May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Current Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.86 6.40 8.39 6.68 3.59

Competitive Comparison

For the Biotechnology subindustry, OptiBiotix Health's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiBiotix Health Current Ratio Distribution

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's Current Ratio distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's Current Ratio falls into.



OptiBiotix Health Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

OptiBiotix Health's Current Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Current Ratio (A: Dec. 2022 )=Total Current Assets (A: Dec. 2022 )/Total Current Liabilities (A: Dec. 2022 )
=1.857/0.278
=6.68

OptiBiotix Health's Current Ratio for the quarter that ended in Jun. 2023 is calculated as

Current Ratio (Q: Jun. 2023 )=Total Current Assets (Q: Jun. 2023 )/Total Current Liabilities (Q: Jun. 2023 )
=1.844/0.514
=3.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OptiBiotix Health  (LSE:OPTI) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


OptiBiotix Health Current Ratio Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health (LSE:OPTI) Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.

OptiBiotix Health (LSE:OPTI) Headlines

From GuruFocus